4
Changes in Ownership
MIRA PHARMACEUTICALS, INC. Filed Acc 0001493152-26-014697
Options or other derivatives
- Chief Executive Officer acquired 83,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Aminov Erez Chief Executive Officer | 2026-03-30 | Grant or award · Restricted Stock Units | +83,500 | 83,500 | D: show line 1 in the form |
Loading xslF345X06/ownership.xml…